Corona Remedies Ltd is a pharmaceutical company involved in manufacturing and marketing branded formulations across chronic and acute therapy areas. The business operates in women’s health, cardio-diabetes, dermatology, pain management and urology. With growing domestic presence, the company is entering the primary market through the Corona Remedies IPO, drawing attention from investors tracking upcoming IPO opportunities.
IPO Name
The official name of the issue is the Corona Remedies Limited IPO. It is a mainboard, book-built issue worth ₹655.37 crore, offered entirely as an Offer for Sale (OFS) by existing shareholders.
IPO Price Band and Lot Size
The Corona Remedies IPO comes with a clearly defined pricing structure and lot allocation:
- Price Band: ₹1,008 to ₹1,062 per share
- Lot Size: 14 shares per lot (and multiples of 14)
This structure allows retail investors to participate with a minimum application of 14 shares. For traders evaluating Corona Remedies GMP or gmp ipo sentiment, the upper band often helps estimate potential listing performance.
IPO Open & Close Date
The subscription window is short, so timing is essential for investors:
- IPO Open Date: 8 December 2025
- IPO Close Date: 10 December 2025
These days typically witness active monitoring of IPO GMP today, bids received, and live IPO GMP trends.
Listing Date
After allotment finalisation and share credit, the company is expected to list on:
- Listing Date: 15 December 2025 (tentative)
Many investors compare the actual listing price with the last known IPO GMP live to estimate how well the IPO has been received by the market.
Grey Market Premium (GMP)
The grey market premium reflects unofficial demand for the IPO before listing. Recent market discussions suggest the Corona Remedies IPO GMP remains strong, reportedly around ₹300–₹365 per share. This indicates healthy interest, though GMP levels are not guaranteed predictors of listing performance.
Corporate Events and Use of Offer
Since the IPO is a complete OFS, the company will not receive fresh capital. However, listing offers several benefits such as:
- Stronger market visibility and brand recognition
- Liquidity for existing shareholders
- Better valuation discovery for future fund-raising
Dividend
Future dividend payout depends on earnings, cash flows and expansion priorities. Investors seeking dividend income should refer to the company’s financial track record and its stated policy in offer documents.
Bonus
No bonus issue is currently attached to this IPO. Any future corporate actions such as splits or bonuses will be announced separately.
Steps to Check IPO Allotment Status
To check the Corona Remedies IPO allotment status once the issue closes:
- Visit the official registrar or stock exchange allotment page after the allotment date.
- Select “Corona Remedies Limited IPO” from the list.
- Enter your PAN, application number or DP/Client ID.
- Submit the details to view allotment status.
This also helps investors track the Corona Remedies IPO subscription status and understand final allocation.
Disclaimer
This article summarises publicly available information on Corona Remedies IPO, IPO GMP, dates, price band, lot size and Corona Remedies IPO GMP subscription status. GMP data is unofficial and subject to change. This is not investment advice. Investors should read the RHP/Prospectus and consult a financial expert before applying.
FAQs
Q1. What is the Corona Remedies IPO price band and lot size?
The price band is ₹1,008–₹1,062 per share, and the minimum lot size is 14 shares.
Q2. What is the Corona Remedies IPO GMP today?
The GMP is reportedly in the range of ₹300–₹365, but it is an informal indicator and may vary.
Q3. When will Corona Remedies list on the stock exchange?
The tentative listing date is 15 December 2025.
